Search results for: 'drip integration of termin ad ai'

30 Jan 2024  |  Global  |  Market Research

Technology Advances Enabling Sugar Reduction in Food and Beverage Products

A Visionary Perspective on R&D and Innovation Efforts

Infographics

×

Sugar reduction has become mainstream in the food and beverages (F&B) industry as end consumers increasingly focus on healthier food choices. As research highlights that overindulgence in sugar can lead to chronic health conditions, regulatory authorities are actively establishing guidelines that mandate the reduction of sugar in various products. ...

20 May 2024  |  Global  |  Market Outlook

Global ADAS and Autonomous Driving Outlook and Growth Opportunities, 2024

Automated Parking and Increased Penetration of Eyes-off Driving Technologies Will Ensure Future Growth Potential of the Autonomous Driving Industry

Infographics

×

The automotive industry faces many challenges, such as regulatory hurdles, semiconductor shortages, and geopolitical chaos. Original equipment manufacturers (OEMs) and value chain partners are realigning their product strategies, road maps, and launch timelines to adapt to these challenges. They have rerouted investments to develop and deploy hands...

Drawing on recent internal strategic imperative analyses of the data centre sector, the industry is entering a period of unprecedented growth, driven by the convergence of AI, energy constraints, and digital infrastructure expansion. Key growth opportunities are emerging as operators transition from traditional facility-focused models toward AI-rea...

The story for 2024 is artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI, particularly generative AI (GenAI), to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption among customers by developing foundational models and user-friend...

Intelligent automation is driven by artificial intelligence (AI) technologies. In industrial operations, AI acts as the catalyst to increase the productivity in the operations. Three types of artificial technology are identified as a game-changer in industrial operations in which these technologies are digitalizing and streamlining the value chain ...

12 Mar 2025  |  Global  |  Technology Research

Emerging Semiconductor Technologies in the Manufacturing Industry

Innovative Materials and Chips Transforming Smart Manufacturing

Infographics

×

The semiconductor industry is pivotal to enabling next-generation technologies, such as quantum computing, AI, and machine learning (ML) accelerators, transforming manufacturing processes. Quantum chips are being explored for their potential to solve complex optimization problems, while AI and ML accelerators are enabling faster data processing and...

22 Jan 2026  |  Global  |  Market Research

Email Security Market, Global, 2023–2028

Email Security will Experience Transformational Growth by 2028

Infographics

×

The global email security market is entering an accelerated phase of transformation, driven by AI-intensified threats, architectural convergence, and rising regulatory scrutiny across all major regions. From 2023 to 2028, the industry will expand from $6.07 billion to more than $11.1 billion, as organizations overhaul legacy defenses and shift towa...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...